首页 | 本学科首页   官方微博 | 高级检索  
检索        

???????????????????????
引用本文:刘震宇.???????????????????????[J].中国实用内科杂志,2011,31(5):343-345.
作者姓名:刘震宇
作者单位:中国医学科学院北京协和医院心内科;
摘    要:冠心病和肿瘤并存的情况越来越常见。肿瘤本身及其治疗影响冠状动脉介入术(PCI)的安全性,PCI术后的二联抗血小板治疗也影响肿瘤的手术治疗。因此,肿瘤患者应尽量避免PCI。肿瘤手术前是否进行预防性PCI取决于术前心脏风险评估的结果。PCI只适用于冠状动脉病变严重或不稳定的肿瘤患者,治疗方式应优选单纯球囊扩张或植入金属裸支架。

关 键 词:冠状动脉粥样硬化性心脏病  肿瘤  经皮冠状动脉介入

Percutaneous Coronary Intervention in Patients with Tumor
LIU Zhen-yu.Percutaneous Coronary Intervention in Patients with Tumor[J].Chinese Journal of Practical Internal Medicine,2011,31(5):343-345.
Authors:LIU Zhen-yu
Institution:LIU Zhen-yu.Department of Cardiology Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China
Abstract:Coronary artery disease and tumor are more and more frequently coexist.Tumor per se as well as its treatment may influence the safety of percutaneous coronary intervention(PCI),while dual antiplatelet therapy associated with PCI may delay the surgery for tumor.So PCI should be avoided as much as possible in tumor patients.Prophylactic PCI should not be performed unless after meticulous preoperative cardiac risk assessment.PCI is only indicated in tumor patients with unstable or severe coronary artery diseas...
Keywords:coronary artery disease  tumor  percutaneous coronary intervention  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实用内科杂志》浏览原始摘要信息
点击此处可从《中国实用内科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号